Cancer immunotherapy using anti-TIM3/PD-1 bispecific antibody: a patent evaluation of EP3356411A1

.

Source: Expert Opinion on Therapeutic Patents - July 3, 2019 Category: Drugs & Pharmacology Authors: Irma Herrera-Camacho Maricruz Anaya-Ruiz Martin Perez-Santos Lourdes Mill án-Pérez Peña Cindy Bandala Gerardo Landeta Source Type: research